Certificate under Reg. 74(5) of SEBI (DP) for the quarter ended 31122025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kobo Biotech Limited has submitted a routine compliance certificate to BSE for the quarter ended 31 December 2025, as required under SEBI's Depositories and Participants Regulations, 2018. The certificate, issued by the company's Registrar and Share Transfer Agent (XL Softech Systems Ltd.), confirms that all share certificates received for dematerialisation during the quarter were properly verified, confirmed to the depositories, mutilated, and cancelled, with the depository's name substituted as the registered owner within 30 days. The letter is signed by Namrata Randeri, an Insolvency Professional, and references a CIRP-specific email (cirp.kobobiotech@gmail.com), indicating the company is currently under Corporate Insolvency Resolution Process. This is a standard procedural filing required of listed companies and does not contain any financial or operational update.
This is a routine regulatory compliance filing and is unlikely to have any direct impact on the stock price. However, the involvement of an Insolvency Professional as signatory highlights that the company remains under CIRP, which continues to be the key overhang on the stock.